HMT-DTI:使用变压器进行分层元路径学习,用于药物向相互作用预测
1School of Computer Science and Technology, Soochow University, Suzhou,China.
概括
这项研究引入了HMT-DTI,这是一种用于药物向相互作用 (DTI) 预测的新框架. 通过学习复杂生物网络中的层次元路径,HMT-DTI提高了准确性和效率.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 药物标相互作用 (DTI) 的预测对于确定治疗标至关重要.
- 目前的DTI方法在复杂的图形语义和计算效率方面扎.
研究的目的:
- 提出HMT-DTI,一个分层的元路径学习框架,用于高效和准确的DTI预测.
- 解决捕获高阶语义关系和整合多元元路径信息的局限性.
主要方法:
- HMT-DTI使用的是预计算式的层次化元路径学习框架.
- 采用基于变压器的消息传递,用于自适应的元路径收集和偶关系传播以提高效率.
- 包含层次知识提取,用于细粒度的语义表示学习.
主要成果:
- HMT-DTI有效地捕获药物和目标之间的丰富的语义信息.
- 与现有方法相比,显示出高计算效率.
- 在三种异构的生物数据集中实现DTI预测的卓越性能.
结论:
- HMT-DTI为药物向相互作用预测提供了一种卓越的方法.
- 该框架提高了药物发现和重新利用的准确性和计算效率.
- HMT-DTI有效地模拟生物网络中的复杂关系.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.7K
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.5K
相关概念视频
Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Drug Biotransformation: Overview
2.5K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.5K
Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
